HOME
About US
Who We Are Management Team R&D Team Accreditation Our Culture
CDMO Services
Polymorph and Crystallization Topical & Transdermal Delivery Complex Generics Accelerated FIH Development GMP Manufacturing Analytical Testing
Proprietary Technology
Products
Pipeline Rx Products OTC Products
Contact us
Contact Us
CN
PRODUCT CENTER
Pipeline Rx Products OTC Products
HOME > Pipeline
Innovative Drugs
Product Name/Code
Type
Indication
Preclinical
Clinical
NDA
Approval
Target Market
ITR 2202
505b(2)
Acne
ITR 2401
505b(2)
Androgenetic Alopecia
Complex Generics
Product Name/Code
Type
Indication
Development Progress
Filing
Approval
Target Market
Lidocaine & Prilocaine Cream
505(j)
Analgesic
Crisaborole Ointment
505(j)
Dematitis
Desonide Ointment
505(j)
Corticosteroid
Adapalene Gel
505(j)
Acne
Agomelatine Tablets
505(j)
Depression
Tacrolimus Capsules
505(j)
Transplant Rejection
PF012
505(j)
Hyperphosphatemia
PF017
505(j)
Kidney Tumor
PF018
505(j)
Transplant Rejection
FD2104
505(j)
Onychomycosis
FD2108
505(j)
Skin Infection
FD2109
505(j)
Acne
FD2205
505(j)
Corticosteroid
FD2206
505(j)
Acne
FD2207
505(j)
Acne
FD2208
505(j)
Psoriasis
FD2301
505(j)
Primary Myelofibrosis
FD2302
505(j)
Dematitis & Vitiligo
FD2304
505(j)
Dematitis & Arthrophlogosis
FD2401
505(j)
Analgesic